Study of T-PRED(TM) Compared to Pred Forte(R)
Overview
Study of T-PRED(TM) compared to Pred Forte(R)
Study Type
- Study Type: Interventional
- Study Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Primary Purpose: Basic Science
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Study Primary Completion Date: August 2008
Interventions
- Drug: T-PRED
- T-PRED sterile ophthalmic solution
- Drug: Pred Forte
- Pred Forte sterile ophthalmic solution
Arms, Groups and Cohorts
- Active Comparator: T-Pred
- Tobramycin prednisolone acetate combination
- Active Comparator: Pred Forte
- Prednisolone acetate
Clinical Trial Outcome Measures
Primary Measures
- Mean Aqueous Humor Prednisolone Acetate Concentration
- Time Frame: 4 hours
Participating in This Clinical Trial
Inclusion Criteria
- 18 years of age Exclusion Criteria:
- No active or adverse disease
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: N/A
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Bausch & Lomb Incorporated
- Provider of Information About this Clinical Study
- Sponsor
- Overall Official(s)
- Tim McNamara, PharmD, Study Director, ISTA Pharmaceuticals, Inc.
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.